Notable
GEMA-proN · Gene Molecular Alterations as Disease Prognostic Markers · Non-small Cell Lung Cancer (NSCLC)
Study completion date changed from estimate of May 15, 2025 to Jul 15, 2026
Also in this update: Trial completed
Hellenic Cooperative Oncology GroupNot specified NCT06876402 Registry history of NCT06876402 on ClinicalTrials.gov (opens the registry)